Black Rock Inc. Arrowhead Pharmaceuticals, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ARWR
# of Institutions
300Shares Held
98MCall Options Held
306KPut Options Held
432K-
Vanguard Group Inc Valley Forge, PA13.2MShares$205 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$173 Million2.29% of portfolio
-
State Street Corp Boston, MA7MShares$109 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$81.4 Million1.32% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL4.79MShares$74.5 Million0.02% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.65B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...